LON:TSTLTristel Share Price, Forecast & News

GBX 475.30

+6.80 (+1.45 %)

(As of 05/26/2020 06:40 AM ET)

Add

Compare

Today's Range

462.11

Now: GBX 475.30▼

475.30

50-Day Range

405

MA: GBX 486.71▼

525

52-Week Range

260

Now: GBX 475.30▼

534

Volume45,316 shs

Average Volume35,859 shs

Market Capitalization£215.11 million

P/E Ratio45.89

Dividend Yield1.14%

BetaN/A

Tristel Plc develops, manufactures, and supplies infection and contamination control, and hygiene products in the United Kingdom, Germany, and internationally. The company operates through three segments: Human Healthcare, Animal Healthcare, and Contamination Control. It offers hospital infection prevention and control products under the Tristel brand; contamination control products for pharmaceutical and personal care industries under the Crystel brand; and animal health infection prevention and control products under the Anistel brand. Tristel Plc was founded in 1993 and is based in Snailwell, the United Kingdom.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Tristel.

2.0 Community Rank

Outperform Votes
Tristel has received 146 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Tristel has received 220 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Tristel has received 60.11% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Tristel and other stocks. Vote “Outperform” if you believe TSTL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TSTL will underperform the S&P 500 over the long term. You may vote once every thirty days.

2.5 Dividend Strength

Dividend Leadership
Tristel is a leading dividend payer. It pays a dividend yield of 1.14%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Tristel does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Tristel is 59.41 %. This payout ratio is at a healthy, sustainable level, below 75%.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Tristel insiders have sold more of their company's stock than they have bought. Specifically, they have bought GBX 0 in company stock and sold £678,924.13 in company stock.

0.0 Earnings and Valuation

Earnings Growth
Earnings for Tristel are expected to decrease by -100.00% in the coming year, from GBX 1,200 to GBX 0 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Tristel is 45.89, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 13.08.
Price to Earnings Ratio vs. Sector
The P/E ratio of Tristel is 45.89, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 20.40.
Price to Book Value per Share Ratio
Tristel has a P/B Ratio of 8.75. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

0.90 out of 5 stars

Industry, Sector and Symbol

Stock Exchange LON

Industry Medical Instruments & Supplies

Sub-IndustryN/A

SectorMedical

Current SymbolLON:TSTL

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.tristel.com

Phone+44-1638-721500

Debt

Debt-to-Equity Ratio16.09

Current Ratio3.15

Quick Ratio2.43

Price-To-Earnings

Trailing P/E Ratio45.89

Forward P/E Ratio0.40

P/E GrowthN/A

Sales & Book Value

Annual Sales£28.79 million

Price / Sales7.47

Cash FlowGBX 8.63 per share

Price / Cash Flow55.05

Book ValueGBX 54.30 per share

Price / Book8.75

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Employees121

Outstanding Shares45,258,000

Market Cap£215.11 million

Next Earnings DateN/A

OptionableNot Optionable

Receive TSTL News and Ratings via Email

Sign-up to receive the latest news and ratings for TSTL and its competitors with MarketBeat's FREE daily newsletter.

Tristel (LON:TSTL) Frequently Asked Questions

How has Tristel's stock been impacted by COVID-19 (Coronavirus)?

Tristel's stock was trading at GBX 455 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, TSTL stock has increased by 4.5% and is now trading at GBX 475.30. View which stocks have been most impacted by Coronavirus.

How were Tristel's earnings last quarter?

Tristel Plc (LON:TSTL) released its quarterly earnings results on Monday, February, 24th. The company reported $5.37 earnings per share for the quarter. View Tristel's earnings history.

How often does Tristel pay dividends? What is the dividend yield for Tristel?

Tristel announced a dividend on Monday, February 24th. Stockholders of record on Thursday, March 26th will be paid a dividend of GBX 2.34 per share on Thursday, April 30th. This represents a yield of 0.53%. The ex-dividend date of this dividend is Thursday, March 26th. The official announcement can be viewed at this link. View Tristel's dividend history.

Has Tristel been receiving favorable news coverage?

News headlines about TSTL stock have trended very negative this week, according to InfoTrie. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Tristel earned a news impact score of -3.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutTristel.

Who are some of Tristel's key competitors?

Some companies that are related to Tristel include Advanced Medical Solutions Group (AMS), Clover (CLV), InfuSystem (INFU), Bovie Medical (BVX), CRH Medical (CRH), Retractable Technologies (RVP), CRH Medical (CRHM), CRH Medical (CRHM), SDI (SDI), Milestone Scientific (MLSS), Omega Diagnostics Group (ODX), Daxor (DXR), Daxor (DXR), IsoRay (ISR) and IsoRay (ISR). View all competitors.

What other stocks do shareholders of Tristel own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tristel investors own include Standard Life Aberdeen (SL), Barclays (BARC), BP (BP), Capital One Financial (COF), De La Rue (DLAR), Man Group (EMG), McCarthy & Stone (MCS), Mediclinic International (MDC), Meggitt (MEGGF) and Sprott Physical Gold Trust (PHYS).

Who are Tristel's key executives?

Tristel's management team includes the following people:

Mr. Paul C. Swinney, CEO & Exec. Director (Age 60)
Ms. Elizabeth A. Dixon, Fin. Director, Company Sec. & Exec. Director (Age 49)
Mr. Bart Victor Margaretha Leemans, Exec. Director (Age 56)

What is Tristel's stock symbol?

Tristel trades on the London Stock Exchange (LON) under the ticker symbol "TSTL."

How do I buy shares of Tristel?

Shares of TSTL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Tristel's stock price today?

One share of TSTL stock can currently be purchased for approximately GBX 475.30.

How big of a company is Tristel?

Tristel has a market capitalization of £215.11 million and generates £28.79 million in revenue each year. Tristel employs 121 workers across the globe.

What is Tristel's official website?

The official website for Tristel is www.tristel.com.

How can I contact Tristel?

Tristel's mailing address is Lynx Business Park,Fordham Road, SNAILWELL, CB8 7NY, United Kingdom. The company can be reached via phone at +44-1638-721500.

This page was last updated on 5/26/2020 by MarketBeat.com Staff